menu search

Sap has now become more attractive

SAP has a significant growth opportunity with a projected 23.52% FCF and 28.48% net profit CAGR over the next 5 years. The stock has dropped 38% from ...

May 12, 2022, 3:40 am

Poolbeg pharma appoints a drug manufacturer ahead of its flu trial next month

Preparations continue apace for Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) ahead of its clinical trial of POLB 001, a treatment for...

May 12, 2022, 2:20 am

Lordstown ceo ninivaggi made $5 million last year

Lordstown may not survive to see the end of 2022. Its finances are in tatters, and its ability to produce vehicles has been...

May 11, 2022, 9:30 am

My best faang stock to buy now and hold forever

Wall Street is severely underestimating Amazon's growth potential....

May 10, 2022, 7:05 am

Intuitive surgical faces more challenges

Intuitive Surgical has massively outperformed the S&P 500 as well as the iShares IHI and is now in the middle of a...

May 10, 2022, 3:56 am

The chinese slowdown: much more than covid

The most recent macroeconomic figures show that the Chinese slowdown is much more severe than expected ...

May 7, 2022, 1:45 pm

Prosus: deep discount on nav cannot be ignored

Prosus is a smart way to buy Tencent. This holding company is severely undervalued compared to NAV, alt...

May 6, 2022, 8:51 am

Argenx to present at bofa securities 2022 healthcare conference

May 4 , 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffe...

May 4, 2022, 1:00 am

Eni: 10% yield with even higher shareholder returns on the horizon

Only roughly one year after reducing their dividends during the now infamously severe downturn of 2020,...

May 2, 2022, 7:57 am

Gores guggenheim would make sense were it not for inflation

On the surface, GGPI stock is an exciting EV alternative. But because of the severe economic backdrop, ...

April 29, 2022, 11:04 am

Ark funds vs. other active etfs: trends show value trumping growth

ARK Invest's products offer exposure to technological innovation in an actively-managed wrapper. Present ratio cool-offs in valuations...

April 29, 2022, 5:14 am

Argenx to report first quarter 2022 financial results and business update on may 5, 2022

April 28, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suf...

April 28, 2022, 1:00 am

Amazon warehouse collapse probe finds worker safety risks

U.S. regulators are calling on Amazon to improve its procedures for dealing with severe weather like hu...

April 27, 2022, 4:11 am

Nordstrom survived and is now ready to thrive

Nordstrom was severely affected by the pandemic, but it has now for the most part recovered and is agai...

April 26, 2022, 9:46 pm

Coinbase: my reverse dcf proves how cheap it is

At a share price of $133.50, the market is severely under-anticipating Coinbase's future growth. Accord...

April 26, 2022, 2:23 pm

Why protagonist therapeutics shares are crashing today

Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2 IDEAL study of PN-943 in moderate-to-severe ulcerative colit...

April 26, 2022, 10:05 am

Scynexis's oral ibrexafungerp shows potency against severe fungal infections

SCYNEXIS Inc (NASDAQ: SCYX) has announced interim data from its ongoing Phase 3 FURI and CARES studies of ibrexafungerp in...

April 22, 2022, 3:15 pm

Best buy proves to be a big winner, having survived major dynamic shifts

Best Buy Co. is a leading American tech retailer, catering to consumers and end-users seeking a plethora of wide-ranging electronic and digital device...

April 21, 2022, 2:50 pm

Raymond james analyst doesn't expect arcturus' covid-19 vaccine to be authorized in the u.s.

Shares of Acturus Therapeutics Holdings Inc. ARCT, -1.43% were down 2.3% in trading on Wednesday after the company said two doses of its experimental ...

April 20, 2022, 1:09 pm

Abbvie snags another regulatory approval for this blockbuster drug

The company's immunology drug Rinvoq was given the go-ahead to treat adult patients with moderate-to-severe ulcerative colitis....

April 20, 2022, 6:40 am


Search within

Pages Search Results: